Call Now: +1 858 800 3101 Email: info@innopep.com
Shopping Cart
0 Item(s) - $0.00
Your shopping cart is empty!
QF - ERP7, FRET
| Overview | |
|---|---|
| Description | This FRET peptide, structurally related to enkephalins, proved to be suitable for assaying the endooligopeptidase A activity. Endooligopeptidase A is a putative neuropeptide-metabolizing enzyme. It converts small enkephalin-containing peptides into the corresponding enkephalins and inactivates biopeptides such as bradykinin and neurotensin in vitro. The enzyme only splits the L-R bond, a reaction efficiently blocked by anti-endooligopeptidase A antibodies. Evidence based on the action of inhibitors and on the analysis of QF-ERP7 fragments demonstrated that endooligopeptidase A contributes 100% of the QF-ERP7 cleaving activity found in the cytosol of rabbit brain homogenates. |
| Sequence | Abz-GGFLRRV-EDDnp |
| Sequence (3 Letter) | Abz-Gly-Gly-Phe-Leu-Arg-Arg-Val-EDDnp |
| Molecular Weight | 1132.4 |
| Properties | |
| Purity | > 95% By HPLC |
| Storage | Store at -20 °C, cap vial tightly at all times. |
Juliano, L. et al. Biochem. Biophys. Res. Commun. 173, 647 (1990); Ferro, E. et al. J. Cell Biochem. 57, 311 (2004).
About InnoPep
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.